| Dr Amartha Nnegi Gore, MD | |
|
834 W Meeting St Ste E1, Lancaster, SC 29720-6251 | |
| (803) 804-5531 | |
| Not Available |
| Full Name | Dr Amartha Nnegi Gore |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 834 W Meeting St Ste E1, Lancaster, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457714685 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geary Community Hospital | Junction city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stormont Vail Health Flint Hills Llc | 9032587472 | 36 |
News Archive
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, announced the signing of an agreement today for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase the technology from Stemedica's wholly-owned subsidiary, Stemedica International, S.A.
In the most comprehensive review to date addressing the relative safety of hormone therapy for transgender persons, researchers from Boston University School of Medicine have found that hormone therapy in transgender adults is safe. The findings, which appear in the Journal of Clinical and Translational Endocrinology, may help reduce the barriers for transgender individuals to receive medical care.
Clinical eating disorders have one of the highest mortalities of any psychiatric category. They can be long lasting and life blighting. However, too often they are thought of by the general public, and sometimes even by health care professionals, either as trivial and perhaps glamorous or as rare and extraordinary.
XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that its over-the-counter (OTC) pain reliever, Cobroxin, will be available for purchase in Walgreens by May 1, 2010. Walgreens is considered one of the nation's largest pharmacy chains with 7,162 drugstores located throughout the United States.
› Verified 1 days ago
| Entity Name | Kingman Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265423917 PECOS PAC ID: 6901791367 Enrollment ID: O20040216001173 |
News Archive
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, announced the signing of an agreement today for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase the technology from Stemedica's wholly-owned subsidiary, Stemedica International, S.A.
In the most comprehensive review to date addressing the relative safety of hormone therapy for transgender persons, researchers from Boston University School of Medicine have found that hormone therapy in transgender adults is safe. The findings, which appear in the Journal of Clinical and Translational Endocrinology, may help reduce the barriers for transgender individuals to receive medical care.
Clinical eating disorders have one of the highest mortalities of any psychiatric category. They can be long lasting and life blighting. However, too often they are thought of by the general public, and sometimes even by health care professionals, either as trivial and perhaps glamorous or as rare and extraordinary.
XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that its over-the-counter (OTC) pain reliever, Cobroxin, will be available for purchase in Walgreens by May 1, 2010. Walgreens is considered one of the nation's largest pharmacy chains with 7,162 drugstores located throughout the United States.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amartha Nnegi Gore, MD Po Box 751649, Charlotte, NC 28275-1649 Ph: (888) 472-0043 | Dr Amartha Nnegi Gore, MD 834 W Meeting St Ste E1, Lancaster, SC 29720-6251 Ph: (803) 804-5531 |
News Archive
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, announced the signing of an agreement today for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase the technology from Stemedica's wholly-owned subsidiary, Stemedica International, S.A.
In the most comprehensive review to date addressing the relative safety of hormone therapy for transgender persons, researchers from Boston University School of Medicine have found that hormone therapy in transgender adults is safe. The findings, which appear in the Journal of Clinical and Translational Endocrinology, may help reduce the barriers for transgender individuals to receive medical care.
Clinical eating disorders have one of the highest mortalities of any psychiatric category. They can be long lasting and life blighting. However, too often they are thought of by the general public, and sometimes even by health care professionals, either as trivial and perhaps glamorous or as rare and extraordinary.
XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that its over-the-counter (OTC) pain reliever, Cobroxin, will be available for purchase in Walgreens by May 1, 2010. Walgreens is considered one of the nation's largest pharmacy chains with 7,162 drugstores located throughout the United States.
› Verified 1 days ago
Mr. Richard E Townsend, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 834 West Meeting Street, Suite B, Lancaster, SC 29720 Phone: 803-286-4405 Fax: 803-286-8487 | |
Trevor George Robinson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 W Meeting St, Lancaster, SC 29720 Phone: 843-792-1414 | |
Dr. William Boatwright Harris Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 834 W Meeting St Ste E, Lancaster, SC 29720 Phone: 803-285-5900 Fax: 803-285-5909 | |
Nancy L. Burleson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 834 W Meeting St Ste E, Lancaster, SC 29720 Phone: 803-285-5900 | |
Dr. Douglas L. Tiedt, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1370 W Meeting St, Lancaster, SC 29720 Phone: 803-286-6997 Fax: 803-283-3999 |